Statistiques et Modélisation pour les Sciences de la Santé
Publications
Affichage des publications 121 à 150 sur 286 au total
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Lancet Oncology . 15 : 862-873
Articles
voir la publicationEstimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
BMC Medical Informatics and Decision Making . 14 : 53
Articles
voir la publicationModeling the seasonality of Anopheles gambiae s.s. biting rates in a South Benin sanitary zone
Transactions of The Royal Society of Tropical Medicine and Hygiene . 108 : 237-43
Articles
voir la publicationCan we identify response markers to antihypertensive drugs? First results from the Ideal Trial.
Journal of Human Hypertension . : doi: 10.1038/jhh.2014.29
Articles
voir la publicationGemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Federation Francophone de Cancerologie Digestive 9902 phase II randomised study
European Journal of Cancer . 50 : 2975-82
Articles
voir la publicationPhysiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate
Journal of Pharmacokinetics and Pharmacodynamics . 41 ( 2 ) : 173-185
Articles
voir la publicationPhysiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate
Journal of pharmacokinetics and pharmacodynamics . 41 : 159-71
Articles
voir la publicationA physiologically based pharmacokinetic model for Valproic acid in adults and children
European Journal of Pharmaceutical Sciences . 63 : 45-52
Articles
voir la publicationA Physiologically Based Pharmacokinetic Model for Clobazam and Stiripentol in Adults and Children
Pharmaceutical Research . 32 : 144-157
Articles
voir la publicationMethodological choices for the clinical development of medical devices
Medical Devices: Evidence and Research . 7 : 325-34
DOI: 10.2147/MDER.S63869
Articles
voir la publicationA methodological framework for drug development in rare diseases
Orphanet Journal of Rare Diseases . 9 ( 164 ) : 1-10
Articles
voir la publicationDeterminants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study
Drugs & aging . 31 : 601-9
Articles
voir la publicationThe Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Current Pharmaceutical Design . 20 : 6191-6206
Articles
voir la publicationExposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort
Journal of clinical psychopharmacology . 34 : 565-70
Articles
voir la publicationPharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children
The Annals of Pharmacotherapy . 48 : 1580-4
Articles
voir la publicationPharmacokinetic Drug Interaction Between Cyclosporine and Imatinib in Bone Marrow Transplant Children and Model-Based Reappraisal of Imatinib Drug Interaction Profile
Therapeutic Drug Monitoring . 36 : 724-729
Articles
voir la publicationImpact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis
British Journal of Clinical Pharmacology . 78 ( 1 ) : 24-32
DOI: 10.1111/bcp.12289
Articles
voir la publicationComparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population
Journal of the Royal Society Interface . 11 : 20140867
Articles
voir la publicationTranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease
Journal of thrombosis and haemostasis . 12 : 1494-502
DOI: 10.1111/jth.12654
Articles
voir la publicationMultivariate meta-analysis using individual participant data
Research Synthesis Methods . 6 : 157-174
Articles
voir la publicationImproving risk prediction performance for a better guidelines application
Journal of Hypertension . 32 : 1192-1193
Articles
voir la publicationCardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies: Systematic Review and Meta-analysis
JAMA Ophthalmology . 132 : 1317-26
Articles
voir la publicationGuidelines for Managing High Blood Pressure
Journal of the American Medical Association . 312 : 293-294
Articles
voir la publicationThe effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Orphanet Journal of Rare Diseases . 9 : 142
Articles
voir la publicationEffects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
Diabetes and Metabolism . 40 : 169-75
Articles
voir la publicationGeriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients
Journal of Clinical Oncology . 31 ( 11 ) : 1464 - 1470
Articles
voir la publicationGeriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients
Journal of Clinical Oncology . 31 : 1464-70
Articles
voir la publicationVariabilité pharmacocinétique inter- et intra-individuelle lors de traitements par teicoplanine chez les sujets âgés. Inter-individual and intra-individual pharmacokinetic variability during teicoplanin therapy ingeriatric patients
Médecine et Maladies Infectieuses . : 1-4
Articles
voir la publicationBayesian networks: a new method for the modeling of bibliographic knowledge: application to fall risk assessment in geriatric patients
Medical and Biological Engineering and Computing . 51 : 657--64
Articles
voir la publicationCalculation of the first dose of amikacine: evaluation of the current dosage recommendations
Annales Pharmaceutiques Françaises . 71 : 7--12
Articles
voir la publication
Vous aussi, commentez cet article